Literature DB >> 8333923

New insights into the etiology of pre-eclampsia.

C J de Groot1, R N Taylor.   

Abstract

Pre-eclampsia is a pregnancy-specific syndrome of unknown etiology, defined by clinical findings of elevated blood pressure combined with proteinuria and oedema. The decidual portion of the spiral arteries of women who later develop pre-eclampsia does not undergo the normal pregnancy-induced remodelling that converts these vessels to high volume-low resistance conduits. We have postulated that this failure leads to vascular spasm, restricted blood flow, placental ischaemia and the release of toxic substances that enter the maternal circulation, resulting in multi-organ disease. The complex and interwoven pathways of endocrine, paracrine and autocrine factors appear to result in a vicious cycle of endothelial cell dysfunction, which is expressed clinically as pre-eclampsia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8333923     DOI: 10.3109/07853899309147870

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  10 in total

Review 1.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

2.  Recombinant vascular endothelial growth factor 121 attenuates autoantibody-induced features of pre-eclampsia in pregnant mice.

Authors:  Athar H Siddiqui; Roxanna A Irani; Yujin Zhang; Yingbo Dai; Sean C Blackwell; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  Am J Hypertens       Date:  2010-12-23       Impact factor: 2.689

Review 3.  Lighting and fattening--evolving concepts in the pathogenesis of preeclampsia.

Authors:  R N Taylor
Journal:  West J Med       Date:  1996-04

4.  A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q.

Authors:  G A Harrison; K E Humphrey; N Jones; R Badenhop; G Guo; G Elakis; J A Kaye; R J Turner; M Grehan; A N Wilton; S P Brennecke; D W Cooper
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

5.  Long-term presence of angiotensin II type 1 receptor autoantibody reduces aldosterone production by triggering Ca2+ overload in H295R cells.

Authors:  Jinghui Lei; Suli Zhang; Pengli Wang; Yang Liao; Jingwei Bian; Xiaochen Yin; Ye Wu; Lina Bai; Feng Wang; Xiaoli Yang; Huirong Liu
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

6.  Effects of hyperhomocysteinemia on arterial pressure and nitric oxide production in pregnant rats.

Authors:  Derrick L Chandler; Maria T Llinas; Jane F Reckelhoff; Babbette LaMarca; Joshua Speed; Joey P Granger
Journal:  Am J Hypertens       Date:  2009-07-23       Impact factor: 2.689

7.  Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia.

Authors:  Athar H Siddiqui; Roxanna A Irani; Weiru Zhang; Wei Wang; Sean C Blackwell; Rodney E Kellems; Yang Xia
Journal:  Hypertension       Date:  2013-01-02       Impact factor: 10.190

8.  Dexamethasone on absent end-diastolic flow in umbilical artery, in growth restricted fetuses from early-onset preeclamptic pregnancies and the perinatal outcome.

Authors:  Oana Sorina Tica; Andrei Adrian Tica; Doriana Cojocaru; Mihaela Gheonea; Irina Tica; Dragos Ovidiu Alexandru; Victor Cojocaru; Lucian Cristian Petcu; Vlad Iustin Tica
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

9.  4G/5G variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase.

Authors:  Gen Kobashi; Kaori Ohta; Hideto Yamada; Akira Hata; Hisanori Minakami; Noriaki Sakuragi; Hiko Tamashiro; Seiichiro Fujimoto
Journal:  J Epidemiol       Date:  2009-10-17       Impact factor: 3.211

10.  Gestational Hypertension as Risk Factor of Hypertension in Middle-Aged and Older Women.

Authors:  Mariko Watanabe; Toshimi Sairenchi; Keiko Nishida; Koji Uchiyama; Yasuo Haruyama; Hiroshi Satonaka; Toshihiko Ishimitsu; Takanori Yasu; Ichio Fukasawa; Gen Kobashi
Journal:  Int J Environ Res Public Health       Date:  2020-06-05       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.